Alnylam Pharmaceuticals
ALNY
#378
Rank
A$91.11 B
Marketcap
A$689.70
Share price
-1.55%
Change (1 day)
76.66%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company